We very much thank the following for their generous donations in support of ANR 2006.
Children's Neuroblastoma Cancer Foundation. The Children's Neuroblastoma Cancer Foundation (CNCF) is a national voluntary health organization whose mission is to help find a cure for children's neuroblastoma and to improve the lives of children suffering from the disease. The CNCF supports pediatric oncology research for the treatment and cure of children's neuroblastoma and assists patients and their families through service, public education and advocacy.
Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles
German Neuroblastoma Research Society
USC/Norris Comprehensive Cancer Center. USC/Norris is designated by the National Cancer Institute as one of the nation's 39 comprehensive cancer centers.
Alex's Lemonade Stand Foundation: Committed to finding a cure for childhood cancer, Alex's Lemonade Stand Foundation was founded by a young neuroblastoma patient, named Alexandra "Alex" Scott. Despite the fact that Alex fought her own deadly battle with cancer for 7½ years, she started a fundraising movement in her frontyard by selling lemonade to support childhood cancer research. She died in 2004, at the age of 8, knowing that she had raised almost a million dollars to find a cure for other children. Her foundation continues in her name with a mission of finding a cure for childhood cancer.
The Saban Research Institute at Childrens Hospital Los Angeles
The Italian Neuroblastoma Association
NANT - New Approaches to Neuroblastoma Therapy (NANT) consortium. This is a group of 13 Universities and Childrens Hospitals with strong research and treatment programs for neuroblastoma. Working closely together, they test promising new therapies for high-risk and relapsed neuroblastoma. The majority of funding for NANT comes from the National Cancer Institute, but a substantial amount comes from philanthropy. NANT was formed to provide a group of closely collaborating investigators who are linked with laboratory programs developing novel therapies for high-risk neuroblastoma. NANT conducts clinical trials that test new drugs and new combinations of drugs against high-risk neuroblastoma. Those with promising results will then be considered for more extensive national testing.
Pediatric Cancer Research Foundation
Audrey Evans Prize
Tom Fletcher Prize
